Case Studies: Ip Rights and Specific Vaccines
Bibliographic record
Abstract
Numerous intellectual property rights apply to vaccines. Vaccines may be covered by patents, copyrights, trademarks, and trade secrets. In response to various diseases including the pandemic, there have been debates regarding intellectual rights on vaccines. In the end, the federal government only placed an order for 3.2 million pills, fewer than 80,000 of which were filled by February 2023. The exact amount of government financing committed to one of India’s companies has not been made public by the US government. A case study of global companies was unable to create a COVID-19 vaccine that was approved. Long before the COVID-19 pandemic, the global pharmaceutical company was awarded funding from the Gates Foundation for a project called “mRNA vaccine platform for rapid response in case of pandemic preparedness.” Some companies mentioned in its German government development support were disclosed in regulatory filings, along with the government's “transferable and nonexclusive right to utilize any intellectual property created during the sponsored project, in the case of a special public interest.” The Biopharmaceutical company has an in-licensing agreement with a Canadian company and important components for their patented LNP technology, which involves milestone and royalty payments. Additionally, a global biopharmaceutical company signed many contracts to enable the expansion of its vaccine production. The company has a sizable portfolio of patents covering its vaccination technique.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.003 | 0.008 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.001 |
| Bibliometrics | 0.002 | 0.002 |
| Science and technology studies | 0.004 | 0.007 |
| Scholarly communication | 0.005 | 0.007 |
| Open science | 0.001 | 0.004 |
| Research integrity | 0.008 | 0.006 |
| Insufficient payload (model declined to judge) | 0.029 | 0.003 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".